The physiology of the vasculature in the central nervous system (CNS), which includes the blood-brain barrier (BBB) and other factors, complicates the delivery of most drugs to the brain. Different methods have been used to bypass the BBB, but they have limitations such as being invasive, non-targeted or requiring the formulation of new drugs. Focused ultrasound (FUS), when combined with circulating microbubbles, is a noninvasive method to locally and transiently disrupt the BBB at discrete targets. The method presents new opportunities for the use of drugs and for the study of the brain.
INTRODUCTION
The blood-brain barrier (BBB) is a specialized non-permeable barrier in the cerebral microvessels consisting of endothelial cells connected together by tight junctions, a thick basement membrane, and astrocytic endfeet. The tight junctions between the endothelial cells, together with an ensemble of enzymes, receptors, transporters, and efflux pumps of the multidrug resistance (MDR) pathways, control and limit access of molecules in the vascular compartment to the brain by paracellular or transcellular pathways 1 . The presence of the BBB normally serves to protect the brain from bacteria and other substances. However, its presence also excludes 98% of all small-molecule drugs and approximately 100% of large-molecule neurotherapeutics from reaching the brain parenchyma 2, 3 .
In 2000 our laboratory found that if short ultrasound bursts are preceded by an injection of an ultrasound contrast agent, the BBB can be consistently opened without the production of lesions or apparent neuronal damage 4 . The presence of the preformed microbubbles that make up the contrast agent circulating in the vasculature appears to concentrate the ultrasound effects to the blood vessel walls, causing BBB disruption with little effect on the surrounding parenchyma, either through widening of the tight junctions or through activation of transport mechanism 5 . Furthermore, the opening occurred at acoustic power levels orders of magnitude lower than was previously used, making this method substantially easier to apply through the intact skull. For BBB disruption, the sonications have been typically delivered as short (~1-20 ms) bursts applied at a low duty cycle (1-5%) for 0.5-1 min.
METHODS
To examine whether this method could be scaled up to clinical use, we performed experiments in non-human primates to test the feasibility of the method with a MRI-guided focused ultrasound system (MRgFUS) device and to investigate whether the method could be applied without any functional All experiments were done in accordance with procedures approved by the Harvard Medical School Institutional Animal Care and Use Committee. Tests were performed in four adult rhesus macaques (six male, one female, weight: 5-12 kg). The device tested was the ExAblate 4000 low-frequency TcMRgFUS system (InSightec). It consists of a 30 cm diameter hemispherical 1024-element phased array transducer operating at 220 kHz coupled with a 1024-channel driving system, a treatment planning workstation, and a water cooling/circulation/degassing system. The system was integrated with a clinical 3T MRI unit (GE Healthcare). BBB disruption was confirmed via MRI contrast enhancement (Magnevist, 0.1 mmol/kg).
Each animal had five sessions of BBB disruption each over 5-9 weeks with bilateral targets in the hippocampus/lateral geniculate nucleus (LGN) and in the primary visual cortex. At each target, a 3×3 grid of sonications (spacing: 2 cm) was applied to disrupt a volume of approximately 1 cm³. Sonications were 150s long and consisted of 10 ms bursts applied at 1 Hz. The exposure level (peak negative pressure: 130-300 kPa) in these animals was initially determined based on acoustic emission measurements obtained with the passive cavitation detectors. If initial sonications did not result in an increase in harmonic emission, which was found previously to correlate with BBB disruption 6, 7 , sonication was repeated at increased power until an increase was observed. If wideband acoustic emission, a signature for the collapse of the microbubbles that occurs at higher energy ("inertial cavitation") 8 was observed, the power was reduced in later sessions. The sonications were accompanied infusion of the microbubble ultrasound contrast agent Definity (Lantheus) at 20 µl/kg.
The monkeys underwent behavioral testing before and after the sonications to evaluate their visual acuity and higherorder cognitive abilities using an automatic touchscreen apparatus for training monkeys to perform visual discrimination tasks 9 . For several hours each day, in a section of their home cages, the monkeys were given choices between two simultaneously presented symbols; they chose one by touching it, and were given a fluid reward based on the correct choice. This testing should be sensitive to any sonication-induced functional deficits in motor or visual function, memory and learning. To test visual acuity, the symbols displayed were varied in size. At the smallest size tested the monkeys would need to use their central visual fields to discriminate the symbols, so any damage to central vision would be apparent as increased errors for the smaller symbols.
RESULTS
It was possible to produce localized BBB disruption in gray matter structures without MRI-evidence of damage or any other unwanted changes out-side of the target volume. Dynamic steering of the focal point produced contiguous volumes of BBBD in gray matter. MR contrast enhancement was not observed in white matter or in white matter portions of sonicated volumes.
The monkeys were trained to use touchscreens in their home cages to choose between pairs of stimuli to select a reward amount (Fig. 1) . They chose between pairs of symbols and received a fluid reward corresponding to the chosen symbol. Numerals 0-9 corresponded to 0-9 drops and the letters X-Y-W-C-H-U-T-F-K-L-N-R-M-E-A-J represented 10-25 drops. New symbols were introduced in order, and over a period of several months all monkeys learned to accurately distinguish between 26 symbols in that they almost always chose the larger of the two choices. Accurate performance of the task thus requires motor skill, the ability to remember all 26 symbols, and the ability to see and recognize the symbols. Furthermore, we tested these monkeys with symbols varying in height from 2.2 mm to 4.5 cm. Thus we could also evaluate the monkeys' acuity. We then repeatedly targeted BBB disruption bilaterally to the LGN and in the foveal confluence of primary visual cortex and secondary visual areas (V1, V2, V3, V4) over several weeks. If damage occurred to the LGN or central visual cortex, visual acuity should be reduced, which would be apparent as a loss of ability to discriminate the smallest symbols. Results from functional testing are shown in Fig. 6 . After five sessions of volumetric BBB disruption centered on these targets, no changes were observed in the performance of the visual task, and visual acuity was unaffected. Here, the acoustic emission signal was used to guide the exposure level.
CONCLUSION
This work demonstrates the feasibility of reliably and repeatedly inducing focal BBB disruption without significant vascular or brain tissue damage in a clinically-relevant animal model using an MRgFUS system designed for human use. The disruption was possible at both deep and superficial targets, and it was always contained within the sonicated volume. Other than occasional appearance of MRI contrast in the nearby sulci, no effects were observed in the acoustic beam path, and there were no signs of internal reflections or standing waves within the intact skull that led to unexpected results. Furthermore, the animals recovered without evident behavioral effects and no changes were found in visual acuity after repeated BBB disruption at targets in the visual pathway, suggesting that the procedure did not cause functional damage.
Methods that can selectively modulate neuronal function, such as electrical stimulation, transcranial magnetic stimulation, and optogenetics, have gained importance in recent years as the tools capable of measuring and mapping 
